Streamlining Patient Care: Introducing CDI’s New Hydrogen and Methane Breath Test Kit Registration Process for Healthcare Providers

CDI is proud to announce the launch of our new hydrogen and methane breath test kit registration process, designed to optimize the testing experience for healthcare providers and their patients. This streamlined process ensures that patients receive personalized support, enhancing the accuracy and efficiency of test results. Here’s how it simplifies the process for your…

CDI Launches MyGI Gateway™: A Cutting-Edge Provider Portal for Enhanced Patient Care

MyGI Gateway will transform hydrogen and methane breath testing with streamlined kit registration, advanced patient engagement, and analytics throughout the diagnostic process. SALEM, Mass. – October 20, 2023 – Commonwealth Diagnostics International, Inc. (CDI), The Leader In Hydrogen and Methane Breath Testing®, is excited to announce the launch of MyGI Gateway™, a cutting-edge cloud-based provider…

Modern Gastro Issue 3 (Q1 2023) Now Available

The latest functional gastrointestinal (GI) trends are now available in the third issue of Modern Gastro presented by CDI. Featured content in the Q1 2023 issue of Modern Gastro includes: A Letter from CDI’s President & CEO Carbohydrate Malabsorption Disorders 101 Highlights from the latest CDI-hosted GI Trends Webinar SIBO Case Study Additional #GIcommunity Insights…

CDI’s Craig Strasnick Featured in The Root Cause Medicine Podcast with Dr. Carrie Jones

CDI’s President & CEO Craig Strasnick was recently interviewed for The Root Cause Medicine Podcast.  During the episode, Strasnick discusses small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) and how the diagnostic side of GI disturbances provides important data that helps guide research and the development of therapies to help patients find relief.…

CDI and My Total Health Announce Strategic Partnership with CliniOps

Collaboration will accelerate and streamline gastroenterology (GI) clinical trials with an end-to-end platform for patient recruitment, enrollment, and management   Salem, Mass. and Fremont, Calif. – October 20, 2022 – My Total Health Inc., in partnership with Commonwealth Diagnostics International, Inc. (CDI), announced today a strategic partnership with CliniOps in which the companies will collaborate…

CDI ISO 13485-Certified Breath Tests Utilized In The Study of Normal Levels of Hydrogen Sulfide In Human Subjects

Sulfate-reducing bacteria (SRB) in the gut produce Hydrogen Sulfide (H2S) internally and externally in humans. H2S plays an essential role in the control of vascular homeostasis, and ongoing studies have shown that extreme levels of SRB in the gut may cause small intestinal bacterial overgrowth (SIBO). Gastrointestinal disorders such as irritable bowel syndrome, ulcerative colitis,…